semaglutide faa medical nejm Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential Pilot medicals and Fella :

1 Tirzepatide: This is the active ingredient in two different brand-name medications from Eli Lilly and Company 14 : Zepbound: An injectable approved by the FDA for chronic weight management in adults with obesity, or those who are overweight with at least one weight-related condition

For use in horses, dogs, cats, cattle, swine, and sheep

Frequently asked questions Does Kaiser Permanente cover Wegovy for weight loss

Retatrutide arrives as a lyophilized powder in vials

Reviewed and updated: July 22, 2026 TriCareRehabs.com is an independent educational referral and helpline service, not a treatment provider, law firm, military program, government agency, or TRICARE

Generally, the eligibility criteria include having a body mass index (BMI) that categorizes the individual as overweight or obese, typically a BMI of 30 or higher, or a BMI of 27 or higher if accompanied by weight-related health conditions such as type 2 diabetes, hypertension, or dyslipidemia